Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in NUVB — Nuvation Bio Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$1,531,441
+$618,723 QoQ
Shares Held
269,620
+26.7% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 242 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 2% Shared 0% None 98%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. NUVB ranks #126 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in NUVB

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,531,441 269,620
2026-03-31 $912,718 212,755
2025-12-31 $1,709,719 190,817
2025-09-30 $501,139 135,443
2025-06-30 $218,868 112,240
2025-03-31 $244,912 139,155
2024-12-31 $412,566 155,100
2024-09-30 $224,807 98,169
2024-06-30 $211,200 72,329
2024-03-31 $312,526 85,859
2023-12-31 $123,315 81,666
2023-09-30 $113,577 84,759
2023-06-30 $123,134 68,408
2023-03-31 $116,856 70,396
2022-12-31 $145,094 75,570
2022-09-30 $105,851 47,255
2022-06-30 $210,230 64,886
2022-03-31 $533,810 101,485
2021-12-31 $914,395 107,576
2021-09-30 $454,127 45,687
2021-06-30 $236,751 25,430